Please login to the form below
SO Patient
This page shows the latest SO Patient news and features for those working in and with pharma, biotech and healthcare.
Roche’s Actemra fails in late-stage severe COVID-19 study
The theory behind testing Actemra in this patient setting is based on the idea that its anti-inflammatory properties could counteract the overactive inflammatory responses observed in the lungs of critically ... Although this class of drug has failed in
Latest news
-
AZ and Novartis ‘most exposed’ to Senate pricing proposals
The thrust of the Part D reforms is to close the so-called ‘donut hole’ or patient coverage gap, which starts when costs rose above the plan’s initial coverage limit ( ... $3, 820 at present) and ends when a patient pays $5, 100 out of pocket.
-
Rivals rise as safety issue mars Pfizer’s DMD gene therapy trial
In three of the children, nausea/vomiting could be controlled with oral anti-emetic drugs, but in one case the side effects were so bad the patient had to be hospitalised
-
$450m diagnostics sale will fuel more Syncona biotech funding
Allis added: “We are so proud of our exceptional, patient-focused team for building a successful radiopharmaceuticals business in only five years.
-
Biogen trumpets safety data for Tecfidera follow-up
The efficacy data aside, for Biogen the emphasis is on the safety data with diroximel fumarate as it attempts to position it as a more patient-friendly alternative to Tecfidera, and ... so encourage patients to switch to the new drug if approved as well
-
NICE wants to stop saying ‘no’ – but needs pharma’s co-operation
I think you [the industry] and organisations like NICE have a responsibility to foster a relationship that generates confidence among patient groups so that they believe that this isn't just ... This includes cell and gene therapies such as Novartis’
AZ and Novartis ‘most exposed’ to Senate pricing proposals
Rivals rise as safety issue mars Pfizer’s DMD gene therapy trial
$450m diagnostics sale will fuel more Syncona biotech funding
Biogen trumpets safety data for Tecfidera follow-up
NICE wants to stop saying ‘no’ – but needs pharma’s co-operation
More from news
Approximately 1 fully matching, plus 123 partially matching documents found.
Latest Intelligence
-
Patient-centred drug development: how far have we come and what’s next?
By Jo Fearnhead-Wymbs. Putting the patient at the centre of clinical development’. ... This is also why, as mentioned above, early integration of patient perspectives is so beneficial – it allows us to shape our services from the ground up, in a
-
Understanding the ‘real world’ starts and ends with the patient
The design and delivery of every PRO study must be developed with a view to enhance each patient’s experience, so we. ... What lies ahead? Healthcare systems and how healthcare is delivered will continually evolve, so how do we make sure that the
-
Recruiting patients for real-world studies – the power of a digital campaign
So, how can study sponsors reach such a large body of prospective study participants? ... If so, the recruited sample should reflect the age and gender of the patient population in the therapy area.
-
Empowering patients empowers results
Decentralised clinical trials that can take place from a patient’s home are clearly gaining ground. ... As patient convenience improves, so does compliance and adherence to protocol, which leads to more accurate results and swifter development of new
-
Digitising healthcare
efficiency. In turn, this reduces patient waiting time and enables smart prioritisation for those who require faster care. ... After all, patient care comes first, so regulations and processes must be in place to keep standards high across all settings.
Patient-centred drug development: how far have we come and what’s next?
Understanding the ‘real world’ starts and ends with the patient
Recruiting patients for real-world studies – the power of a digital campaign
Empowering patients empowers results
Digitising healthcare
More from intelligence
Approximately 0 fully matching, plus 57 partially matching documents found.
Latest appointments
-
New faces at Synergy Vision, Makara Health and JPA Health
I’m passionate about delivering projects that challenge the status quo and improve patient outcomes, so this is an incredibly exciting time to be at the forefront of medical communications with ... regional health communications campaigns. In her new
-
Ferring appoints executive VP and chief medical officer
Michel Pettigrew, president of the executive board and chief operating officer, Ferring Pharmaceuticals, said: “Making the industry more patient-centric has always been a top priory for Professor Dugi, and this ... is perfectly aligned with our
-
Sanofi appoints ‘chief patient officer’
The company explained that Dr Beal will be tasked with elevating the 'perspective of the patient within Sanofi so the company's future healthcare offerings can better incorporate the unique priorities ... the patient perspective advances our approach to
New faces at Synergy Vision, Makara Health and JPA Health
Ferring appoints executive VP and chief medical officer
Sanofi appoints ‘chief patient officer’
More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.
Latest from PMHub
-
RESONANT GROUP ACQUIRES PR BUSINESS
creative medical education, so this opportunity was very timely,” said David Youds, CEO and owner of Resonant Group. ... Origins Insights is an award-winning, pioneering health insights agency that delivers actionable, patient-focused intelligence to
-
Overcoming the digital patient recruitment challenges of connecting with patients
That’s where using the psychology behind human behaviour comes in. So, in short: connecting with patients digitally is challenging. ... And gaining patient insights to try to find out what they want, so that you can engage with them effectively,
-
Key benefits of a digital patient recruitment solution
That is why we aim to understand the drivers and barriers behind the decisions made by each patient so we can support them effectively through the process. ... So, why should you use TrialVerse as part of your patient recruitment strategies in clinical
-
How innovating study sites can improve patient recruitment efficiency
So, imagine you’re a patient who’s eligible for a clinical trial. ... So, you can start to understand why patient recruitment can be the least efficient part of a clinical trial.
-
We are looking for new talent! - Quant RM role
We seamlessly integrate brand consultancy with customer and patient insights, so that our client’s strategic choices are made with confidence.
Overcoming the digital patient recruitment challenges of connecting with patients
Key benefits of a digital patient recruitment solution
How innovating study sites can improve patient recruitment efficiency
We are looking for new talent! - Quant RM role
More from PMHub
Approximately 0 fully matching, plus 77 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Account Director, Medical & Brand Communications, London/ SE...
-
Highly competitive salary
- Medical Writers (All levels) Editorial / Scientific Leads & ...
-
Highly Competitive Remuneration packages
- Freelance Scientific Director, Medical Communications, London/ S...
-
Highly competitive salary
- Senior Account Director, Medical & Brand Communications, Lon...
-
Highly competitive salary
- Senior Account Management Trainer, Medical Communications, Londo...
-
Highly competitive salary
- Editorial Director - UK, , EUROPE, REMOTE.
-
Highly Competitive Salary, Bonus &Benefits
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
- Medical Writer, Women’s health, Medical Communications agency, h...
-
Highly competitive salary
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- AstraZeneca’s Imfinzi provides sustained survival benefit for lung cancer patients
- EU “still interested” in Valneva COVID vaccine despite UK snub
- US demand for COVID-19 antibody treatments rising fast
- First oral antiviral drug for COVID-19 reviewed by Health Canada
- Havas Life Medicom and ARK lead at 2021 PM Society Digital Awards
- COVID-19 Pfizer/BioNTech booster approved by FDA and CDC
- AstraZeneca invests in RNA tech platform
- Market shaping demands behaviour change
- Healthcare Access and Payment Reform in the US
- Advancing Drug Discovery with Structured and Intelligent Data
- Fishawack Health appoints Elizabeth Landon in the newly created Chief People Officer role
- David Hunt launches independent agency The Considered
- EU “still interested” in Valneva COVID vaccine despite UK snub
- Oxford PharmaGenesis wins Communiqué Medical Affairs Agency of the Year award at Communiqué 2021
- FDA’s director and deputy director of its Office of Vaccines Research & Review resign
- $47.5m research centre to seek genetic insights into disease
- New data from Moderna supports COVID boosters
PMHub
McCann Health Medical Communications
We are the medical communications experts within McCann Health. Communicating science to bring meaning and positive change to people’s lives....
Latest intelligence
- Robust Review: COVID19 Assessment
- See how our client utilized Rapid Payer Response (RPR) to stay informed and gain continuous insights during the recent global pandemic (COVID19)...
- All change – how untangling human behaviour can encourage better health
- Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence...
- Health literacy in the time of COVID-19
- In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...
